Invention Application
US20170008911A1 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
审中-公开
2-氨基-6-甲基-4,4a，5,6-四氢吡喃并[3,4-d] [1,3]噻唑-8a（8H） - 基] - 噻唑-4-基酰胺
![2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides](/docs/US/2017-01-12/US20170008911A1/abs.jpg.600x600.jpg)
- Patent Title: 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
- Patent Title (中): 2-氨基-6-甲基-4,4a，5,6-四氢吡喃并[3,4-d] [1,3]噻唑-8a（8H） - 基] - 噻唑-4-基酰胺
-
Application No.: US15215193Application Date: 2016-07-20
-
Publication No.: US20170008911A1Publication Date: 2017-01-12
- Inventor: Michael Aaron Brodney , Elizabeth Mary Beck , Christopher Ryan Butler , Lei Zhang , Brian Thomas O'Neill , Gabriela Barreiro , Erik Alphie LaChapelle , Bruce Nelsen Rogers
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D519/00
![2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides](/abs-image/US/2017/01/12/US20170008911A1/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US09605007B2 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides Public/Granted day:2017-03-28
Information query
